BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33104026)

  • 1. Impairment of Everyday Spatial Navigation Abilities in Mild Cognitive Impairment Is Weakly Associated with Reduced Grey Matter Volume in the Medial Part of the Entorhinal Cortex.
    Hallab A; Lange C; Apostolova I; Özden C; Gonzalez-Escamilla G; Klutmann S; Brenner W; Grothe MJ; Buchert R;
    J Alzheimers Dis; 2020; 78(3):1149-1159. PubMed ID: 33104026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between quantitative [
    Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
    Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer's Disease Patients with Depressive Symptoms.
    Brendel M; Sauerbeck J; Greven S; Kotz S; Scheiwein F; Blautzik J; Delker A; Pogarell O; Ishii K; Bartenstein P; Rominger A;
    J Alzheimers Dis; 2018; 65(3):793-806. PubMed ID: 30010116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive dispersion is a sensitive marker for early neurodegenerative changes and functional decline in nondemented older adults.
    Bangen KJ; Weigand AJ; Thomas KR; Delano-Wood L; Clark LR; Eppig J; Werhane ML; Edmonds EC; Bondi MW
    Neuropsychology; 2019 Jul; 33(5):599-608. PubMed ID: 30896235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subtypes: Stratification Based on Imaging Biomarkers.
    Ota K; Oishi N; Ito K; Fukuyama H; ;
    J Alzheimers Dis; 2016 Apr; 52(4):1385-401. PubMed ID: 27079727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal progression of cognitive decline correlates with changes in the spatial pattern of brain 18F-FDG PET.
    Shokouhi S; Claassen D; Kang H; Ding Z; Rogers B; Mishra A; Riddle WR;
    J Nucl Med; 2013 Sep; 54(9):1564-9. PubMed ID: 23864720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
    Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
    Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process.
    González-Redondo R; García-García D; Clavero P; Gasca-Salas C; García-Eulate R; Zubieta JL; Arbizu J; Obeso JA; Rodríguez-Oroz MC
    Brain; 2014 Aug; 137(Pt 8):2356-67. PubMed ID: 24951642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional White Matter Hyperintensity Influences Grey Matter Atrophy in Mild Cognitive Impairment.
    Vipin A; Foo HJL; Lim JKW; Chander RJ; Yong TT; Ng ASL; Hameed S; Ting SKS; Zhou J; Kandiah N
    J Alzheimers Dis; 2018; 66(2):533-549. PubMed ID: 30320575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral and blood correlates of reduced functional connectivity in mild cognitive impairment.
    Gonzalez-Escamilla G; Atienza M; Garcia-Solis D; Cantero JL
    Brain Struct Funct; 2016 Jan; 221(1):631-45. PubMed ID: 25366971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of mild cognitive impairment using an entorhinal cortex-based test of virtual reality navigation.
    Howett D; Castegnaro A; Krzywicka K; Hagman J; Marchment D; Henson R; Rio M; King JA; Burgess N; Chan D
    Brain; 2019 Jun; 142(6):1751-1766. PubMed ID: 31121601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Entorhinal Cortex Atrophy Score Is Diagnostic and Prognostic in Mild Cognitive Impairment.
    Traschütz A; Enkirch SJ; Polomac N; Widmann CN; Schild HH; Heneka MT; Hattingen E
    J Alzheimers Dis; 2020; 75(1):99-108. PubMed ID: 32250289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of ApoE ε4 on longitudinal brain region-specific glucose metabolism in patients with mild cognitive impairment: a FDG-PET study.
    Paranjpe MD; Chen X; Liu M; Paranjpe I; Leal JP; Wang R; Pomper MG; Wong DF; Benzinger TLS; Zhou Y;
    Neuroimage Clin; 2019; 22():101795. PubMed ID: 30991617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.
    Espinosa A; Alegret M; Pesini P; Valero S; Lafuente A; Buendía M; San José I; Ibarria M; Tejero MA; Giménez J; Ruiz S; Hernández I; Pujadas F; Martínez-Lage P; Munuera J; Arbizu J; Tárraga L; Hendrix SB; Ruiz A; Becker JT; Landau SM; Sotolongo-Grau O; Sarasa M; Boada M; ;
    J Alzheimers Dis; 2017; 57(2):447-459. PubMed ID: 28269787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the association between brain atrophy, hypometabolism, and cognitive decline in Alzheimer's disease: a PET/MRI study.
    Chen Y; Wang J; Cui C; Su Y; Jing D; Wu L; Liang P; Liang Z
    Aging (Albany NY); 2021 Feb; 13(5):7228-7246. PubMed ID: 33640881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparametric imaging hippocampal neurodegeneration and functional connectivity with simultaneous PET/MRI in Alzheimer's disease.
    Yan S; Zheng C; Cui B; Qi Z; Zhao Z; An Y; Qiao L; Han Y; Zhou Y; Lu J
    Eur J Nucl Med Mol Imaging; 2020 Sep; 47(10):2440-2452. PubMed ID: 32157432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct pattern of hypometabolism and atrophy in preclinical and predementia Alzheimer's disease.
    Kljajevic V; Grothe MJ; Ewers M; Teipel S;
    Neurobiol Aging; 2014 Sep; 35(9):1973-81. PubMed ID: 24811241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anterolateral Entorhinal Cortex Volume Predicted by Altered Intra-Item Configural Processing.
    Yeung LK; Olsen RK; Bild-Enkin HEP; D'Angelo MC; Kacollja A; McQuiggan DA; Keshabyan A; Ryan JD; Barense MD
    J Neurosci; 2017 May; 37(22):5527-5538. PubMed ID: 28473640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.